
Bioorganic and Medicinal Chemistry Letters p. 2241 - 2246 (1998)
Update date:2022-08-05
Topics:
Sakaki, Junichi
Murata, Toshiki
Yuumoto, Yoko
Nakamura, Ikushi
Frueh, Thomas
Pitterna, Thomas
Iwasaki, Genji
Oda, Kyoko
Yamamura, Takaki
Hayakawa, Kenji
IRL 3461, N-butanesulfonyl-[N-(3,5-dimethylbenzoyl)-N-methyl-3-[4-(5- isoxazolyl)-phenyl]-alanyl]-(L)-valineamide, a potent and bifunctional (ET(A) + ET(B)) [Ki(ET(A))=1.8 nM, Ki(ET(B))=1.2 nM] antagonist was discovered by structural modification of IRL 2500, an ET(B) selective antagonist. IRL 3461 was found to be stable on incubation with human, rat, mouse, and guinea pig plasmas.
View MoreContact:+86-0760-85282375
Address:zhongjing road,zhongshan torch hi-tech industrial development zone
Shanghai PuYi Chem-Tech Co.,Ltd.
Contact:+86-21-57687505-227
Address:3 Floor, Building 11, No 201 MinYi Road, Songjiang District, Shanghai 201612, China
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
shijiazhuang baisheng chem co.; ltd
Contact:86-0311-80790826
Address:shijiazhuang hebei
Suzhou CarbonWell Pharma-Tech Co., Ltd
Contact:Tel: + 86 (0)512-8898-1216; + 86-18606258602
Address:2358 Changan Road, Wujiang Scientific Innovation Park, Wujiang, Jiangsu Province, P. R. China 215200
Doi:10.1016/S0040-4039(96)02032-1
(1996)Doi:10.1021/jo961168z
(1997)Doi:10.1016/S0040-4020(99)00444-5
(1999)Doi:10.1002/anie.201703174
(2017)Doi:10.1016/j.tet.2016.08.001
(2016)Doi:10.1139/v96-244
(1996)